C12P 17/186
Containing a 2-oxo-thieno[3,4-d]imidazol nucleus
Official title: {containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin}
C12P17/186 (Containing a 2-oxo-thieno[3,4-d]imidazol nucleus) appears on 30 US grants and 20 published applications in this corpus.
Search patents in C12P- Granted patents
- 30
- Published applications
- 20
- Assignees
- 25
- Inventors
- 108
- Latest grant
- 26 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 1 |
| 2004 | 1 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 3 |
| 2008 | 2 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Cell factory having improved iron-sulfur cluster delivery26 Dec 2023US 11,851,461 B2Biosyntia Aps
- Hybrid polyketide synthases22 Nov 2022US 11,505,791 B2The Regents of the University of California
- Hybrid polyketide synthases3 Dec 2019US 10,494,625 B2The Regents of the University of California
- Hybrid polyketide synthases10 May 2016US 9,334,514 B2The Regents of the University of California
- Method for producing organically-bound vitamin B25 Mar 2014US 8,679,555 B2JHS-Privatstiftung
- Microbial cell factories producing vitamin b compounds7 Nov 2024US 2024/0368659 A1
- Fermentation process27 Jul 2023US 2023/0235375 A1Dsm IP Assets B.V.
- Cell factory having improved iron-sulfur cluster delivery22 Jun 2023US 2023/0192778 A1Biosyntia Aps
- Biotin synthases for efficient production of biotin3 Nov 2022US 2022/0348974 A1Albert Einstein College of Medicine
- Hybrid Polyketide Synthases27 Aug 2020US 2020/0270597 A1The Regents of the University of Califonia
Most cited
By later US patents
- Biotin biosynthesis in bacillus subtilis21US 6,841,366 B1Dsm IP Assets B.V. · 2005
- Cloning of the bioA, bioD, bioF, bioC and BioH genes of bacillus spraericus, vectors and transformed cells13US 5,096,823 ATransgene S. A. · 1992
- System for biotin synthesis12US 5,110,731 AAmgen Inc. · 1992
- Process for producing biotin-vitamers9US 4,563,426 ANippon Zeon Co., Ltd. · 1986
- Method for isolating mutant cells9US 5,348,872 APresident and Fellows of Harvard College · 1994